Solace Therapeutics
Framingham, US · Delaware corporation · 1 known investors
Founders & leadership
WH
William H. GruberExecutive
KC
Kevin ConnorsExecutive
Board
AB
RD
Ryan DrantBoard director
JD
J. Daniel ColeBoard director
JM
John McDonoughBoard director
SE
Stacy Enxing SengBoard director
KG
Kevin G. ConnorsBoard director
DW
Dr. William PintauroBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$28.4M disclosed across 4 rounds · 2012–2020
▶$6.5MraisedFeb 2021 · 8 investors · Other Health CareRule 506(b)
▶$6.5MraisedFeb 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William H. GruberExecutive Officer, Director
- Kevin G. ConnorsDirector
- Brian R. SmithDirector
- John McDonoughDirector
- David NeustaedterDirector
- Offering amount
- $17.6M
- Amount sold
- $6.5M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedFeb 2019 · 6 investors · Other Health CareRule 506(b)
▶$1.9MraisedFeb 2019 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin G. ConnorsExecutive Officer, Director
- John McDonoughDirector
- Ryan DrantDirector
- Ali BehbahaniDirector
- William H. GruberExecutive Officer, Director
- Stacy Enxing SengDirector
- Offering amount
- $2.1M
- Amount sold
- $1.9M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13MraisedSep 2016 · 2 investors · Other Health CareRule 506(b)
▶$13MraisedSep 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John McDonoughDirector
- Stacy Enxing SengDirector
- Kevin G. ConnorsDirector
- William H. GruberExecutive Officer, Director
- Ali BehbahaniDirector
- Ryan DrantDirector
- Offering amount
- $20M
- Amount sold
- $13M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedMar 2012 · Other Health CareRule 506(b)
▶$7MraisedMar 2012 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin ConnorsExecutive Officer, Director
- Dr. William PintauroDirector
- J. Daniel ColeDirector
- William H. GruberExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $7M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Solace Therapeutics's investors?
- Solace Therapeutics's investors include New Enterprise Associates (NEA).
- How much funding has Solace Therapeutics raised?
- Solace Therapeutics has disclosed $28.4M raised across 4 rounds.
- Where is Solace Therapeutics headquartered?
- Solace Therapeutics is headquartered in Framingham, US.